Oral cannabinoid preparations for the treatment of chronic migraine: a retrospective study.

Baraldi CarloFlavia Lo CastroAndrea NegroAnna FerrariMaria Michela CainazzoLuca PaniSimona Guerzoni

Published in: Pain medicine (Malden, Mass.) (2021)

Oral cannabinoid preparations may have a role in reducing pain intensity and acute medication intake in patients with chronic migraine, but the magnitude of the effect seems modest; further studies are needed.

Keyphrases

chronic pain
drug induced
pain management
neuropathic pain
high intensity
spinal cord injury
combination therapy
intensive care unit
adverse drug
replacement therapy
acute respiratory distress syndrome